ACE2 substrate
Fluorogenic substrate for angiotensin converting enzyme-2 (ACE2), a zinc-dependent carboxypeptidase with 42% amino acid sequence identity to ACE1. Unlike Mca-YVADAPK(Dnp), this substrate is not cleaved by caspases. Mca fluorescence is quenched by the Dnp group until cleavage (at Pro-Lys) separates them. Ex: 328 nm, Em: 393 nm, although the following Ex/Em have also been used: 320-340/400-420. This highly quenched (99.6%) substrate is useful for inhibitor screening and kinetic analysis. Also available: fluorogenic Mca control peptide (BML-P127).
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Product Details
Alternative Name |
ACE2 substrate (fluorogenic) |
---|---|
Appearance |
Yellow powder. |
Formula |
C32H37N6O12 |
Identity |
Determined by MS. |
MW |
696.7 |
Purity |
≥95% (HPLC) |
Sequence |
Mca-Ala-Pro-Lys(Dnp) [Mca=(7-methoxycoumarin-4-yl)acetyl;Dnp=2,4-dinitrophenyl] |
Solubility |
Soluble in DMSO or 10% Ammonium Hydroxide (2 mg/ml). |
Source |
Synthetic. |
Handling & Storage
Use/Stability |
As indicated on product label or CoA when stored as recommended. Stock solutions in DMSO stable at -20°C |
---|---|
Handling |
Protect from light and moisture. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Differential Effects of Losartan and Finerenone on Diabetic Remodeling, Oxidative Stress and ACE Activity in the Gastrointestinal Tract of Streptozotocin-Induced Diabetic Rats: Esteves-Monteiro, M., Vitorino-Oliveira, C., et al.; Int. J. Mol. Sci. 26, 6294 (2025), Abstract
- SGLT2i and GLP1-RA exert additive cardiorenal protection with a RAS blocker in uninephrectomized db/db mice: Martos-Guillami, N., Vergara, A., et al.; Front. Pharmacol. 15, 1415879 (2024), Reactant(s): Mouse, Abstract
- Synthesis of cannabidiol-based compounds as ACE2 inhibitors with potential application in the treatment of COVID-19: G. V. L. Marques, et al.; Eur. J. Med. Chem. 260, 115760 (2023), Abstract
- Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19: M.G. Silva, et al.; Biomed. Pharmacother. 152, 113201 (2022), Abstract
- Enhanced Cardiorenal Protective Effects of Combining SGLT2 Inhibition, Endothelin Receptor Antagonism and RAS Blockade in Type 2 Diabetic Mice: Vergara, A., Jacobs-Cachá, C., et al.; Int. J. Mol. Sci. 23, (2022), Reactant(s): Mouse, Abstract
- Exploring Renal Changes after Bariatric Surgery in Patients with Severe Obesity: A. Oliveras, et al.; J. Clin. Med. 11, 728 (2022), Abstract
- Dysregulation of ACE-1 in Normal Aging and the Early Stages of Alzheimer’s Disease: R. MacLachlan, et al.; J. Gerontol. A Biol. Sci. Med. Sci. 77, 1775 (2022), Abstract
- Activation of angiotensin-converting enzyme 2/angiotensin (1–7)/mas receptor axis triggers autophagy and suppresses microglia proinflammatory polarization via forkhead box class O1 signaling: R. Dang, et al.; Aging Cell 20, 13480 (2021), Abstract
- Apelin-13 in septic shock: effective in supporting hemodynamics in sheep but compromised by enzymatic breakdown in patients: D. Coquerel, et al.; Sci. Rep. 11, 22770 (2021), Abstract
- SARS-CoV-2 Spike Protein Regulation of Angiotensin Converting Enzyme 2 and Tissue Renin-Angiotensin Systems: Influence of Biologic Sex: Ensor, C. M., Alsiraj, Y., et al.; bioRxiv , (2021)
- Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy: V. Palau, et al.; Int. J. Mol. Sci. 22, 5520 (2021), Abstract
- Metabolism of angiotensin peptides by angiotensin converting enzyme 2 (ACE2) and analysis of the effect of excess zinc on ACE2 enzymatic activity: Y. Polak & R.C. Speth; Peptides 137, 170477 (2021), Abstract
- Male bias in ACE2 basic science research: Missed opportunity for discovery in the time of COVID-19: B. Stanic., et al.; Am. J. Physiol. Regul. Integr. Comp. Physiol. 1152, 356 (2021), Abstract
- A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure: D.C. Files, et al.; Am. J. Physiol. Lung Cell. Mol. Physiol. 321, L213 (2021), Abstract
- SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients: L. Gutiérrez-Chamorro, et al.; Viruses 13, 1715 (2021), Abstract
- Role of the Renin Angiotensin System in Blood Pressure Allostasis-induced by Severe Food Restriction in Female Fischer rats: A.M.A. de Souza, et al.; Sci. Rep. 8, 10327 (2018), Abstract
- Chymase-dependent production of angiotensin II: an old enzyme in old hearts: G. Froogh, et al.; Am. J. Physiol. Heart Circ. Physiol. 312, H223 (2017), Abstract
- Serum activity of angiotensin converting enzyme 2 is decreased in patients with acute ischemic stroke: D.M. Bennion, et al.; J. Renin Angiotensin Aldosterone Syst. 17, 1470320316661060 (2016), Reactant(s): Human, Abstract — Full Text
- Estradiol, acting through ERα, induces endothelial non-classic renin-angiotensin system increasing angiotensin 1-7 production: A. Mompeon, et al.; Mol. Cell. Endocrinol. 422, 1 (2016), Abstract
- Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus: Y. Liang, et al.; Kidney Blood Press. Res. 40, 101 (2015), Application(s): Fluorescent Substrate-Based Assay, Abstract — Full Text
- Administration of 17β-estradiol to ovariectomized obese female mice reverses obesity-hypertension through an ACE2-dependent mechanism: Wang, Y., Shoemaker, R., et al.; Am. J. Physiol. Endocrinol. Metab. 308, E1066 (2015), Reactant(s): Mouse, Abstract
- Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence: J.L. Guy, et al.; Biochemistry 42, 13185 (2003), Abstract
- Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase: C. Vickers, et al.; J. Biol. Chem. 277, 14838 (2002), Abstract — Full Text
- ACEH/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors: A.J. Turner, et al.; Can. J. Physiol. Pharmacol. 80, 346 (2002), Abstract
- A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9: M. Donoghue, et al.; Circ. Res. 87, E1 (2000), Abstract — Full Text
Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form